Eric Chin - Apollo Medical COO
| 3AM Stock | EUR 33.00 0.40 1.20% |
COO
Mr. Eric Chin is the Chief Financial Officer of Apollo Medical Holdings, Inc. Mr. Chin was our Chief Financial Officer since July 2018. Mr. Chin has served as the Chief Financial Officer of NMM, one of the Companys subsidiaries, since March 2018. Prior to joining NMM, Mr. Chin served as the ControllerHead of FinanceReal Estate of Public Storage, Inc., a New York Stock Exchange listed company and a member of the SP 500. From May 2011 to October 2015, he served as Assistant VicePresidentFinancial Reporting of Alexandria Real Estate Equities, Inc., a New York Stock Exchange listed company and a member of the SP 500. Mr. Chin began his career at Ernst Young LLP in 2002. In his role as an Assurance Senior Manager at Ernst Young LLP, Mr. Chin provided assurance services to both publicly traded companies and private companies. In addition to providing audit and attestation services, Mr. Chin assisted clients with services related to equity offerings, debt offerings and technical research since 2021.
| Age | 39 |
| Tenure | 3 years |
Apollo Medical Holdings Leadership Team
Elected by the shareholders, the Apollo Medical's board of directors comprises two types of representatives: Apollo Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Apollo. The board's role is to monitor Apollo Medical's management team and ensure that shareholders' interests are well served. Apollo Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Apollo Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Li Yu, Independent Director | ||
| John Chiang, Independent Director | ||
| Ernest Bates, Independent Director | ||
| Kenneth Sim, Chairman of the Board, Co-Chief Executive Officer, Executive Director | ||
| Mitchell Kitayama, Lead Independent Director | ||
| Linda Marsh, Director | ||
| Thomas Lam, President, Co-Chief Executive Officer, Director | ||
| Albert Young, Chief Administrative Officer | ||
| Mark Fawcett, Independent Director | ||
| Brandon Sim, Chief Operating Officer, Chief Technology Officer, Vice President of Engineering | ||
| David Schmidt, Independent Director | ||
| Michael Eng, Independent Director | ||
| Eric Chin, Chief Financial Officer, Interim Co-Chief Operating Officer, Secretary | ||
| Adrian Vazquez, Co-Chief Medical Officer | ||
| Matthew Mazdyasni, Director |
Apollo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Apollo Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 1.28 B | |||
| Price To Book | 2.60 X | |||
| Price To Sales | 1.29 X | |||
| Revenue | 1.14 B | |||
| EBITDA | 112.08 M | |||
| Net Income | 49.05 M | |||
| Total Debt | 203.39 M | |||
| Cash Flow From Operations | 70.33 M | |||
| Number Of Employees | 15 | |||
| Market Capitalization | 197.6 M |
Currently Active Assets on Macroaxis
Other Information on Investing in Apollo Stock
Apollo Medical financial ratios help investors to determine whether Apollo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Apollo with respect to the benefits of owning Apollo Medical security.